The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Tenet Healthcare Corp

NYSE: THC
Last

(U.S.) $51.85

Today's change+0.55 +1.07%
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.
 

Tenet Healthcare Corp

NYSE: THC
Last

(U.S.) $51.85

Today's change+0.55 +1.07%
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.

Tenet Healthcare Corp crosses above 50-day moving average

Tenet Healthcare Corp closed up Friday by (U.S.)$0.55 or 1.07% to (U.S.)$51.85 and crossing above its 50-day moving average. Over the last five days, shares have gained 3.18% and 23.10% year to date. Shares have outperformed the S&P 500 by 15.69% during the last year.

Key company metrics

  • Open(U.S.) $51.62
  • Previous close(U.S.) $51.30
  • High(U.S.) $52.21
  • Low(U.S.) $51.52
  • Bid / Ask-- / --
  • YTD % change+23.10%
  • Volume1,380,041
  • Average volume (10-day)1,631,141
  • Average volume (1-month)1,589,645
  • Average volume (3-month)1,920,757
  • 52-week range(U.S.) $37.95 to (U.S.) $63.61
  • Beta1.92
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward33.28×
  • Forward PEG1.89×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.45
Updated December 19 4:07 PM EST. Delayed by at least 15 minutes.
S&P TSX0.85%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue4,1794,0423,9263,885
Total other revenue--------
Total revenue4,1794,0423,9263,885
Gross profit3,5143,3933,2983,259
Total cost of revenue665649628626
Total operating expense3,9923,8353,7563,718
Selling / general / administrative2,0281,9561,9211,872
Research & development--------
Depreciation / amortization207209193191
Interest expense (income), net operating--------
Unusual expense (income)65442486
Other operating expenses, total1,027977990943
Operating income187207170167
Interest income (expense), net non-operating-186-190-182-182
Gain (loss) on sale of assets--------
Other--------
Income before tax117-12-15
Income after tax199-11-7
Income tax, total-188-1-8
Net income9-26-32-24
Total adjustments to net income------0
Net income before extra. items10-10-27-17
Minority interest-9-19-16-10
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items10-10-27-17
Inc. avail. to common incl. extra. items9-26-32-24
Diluted net income9-26-32-24
Dilution adjustment----0--
Diluted weighted average shares101989799
Diluted EPS excluding extraordinary itemsvalue per share0.10-0.10-0.28-0.17
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.520.14-0.120.39